Kliniska studier för Migrän i Pennsylvania
8 studier för Migrän söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1
Ålder 6 till 11 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06995729MMA Embolization for Refractory Chronic Migraine
- Thomas Jefferson University Hospital, Philadelphia
Rekryterar
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06735833Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Clario, Philadelphia
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 270854, Scottdale
- Frontier Clinical Research - Smithfield /ID# 270849, Smithfield
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Children's Hospital of Philadelphia, Philadelphia
Rekryterar
Ålder 10 till 17 · Alla kön · Uppdaterad 21 sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- University of Pennsylvania, Philadelphia
RekryterarFas 4
Ålder 18 till 70 · Alla kön · Uppdaterad 16 sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 231913, Scottdale
- Frontier Clinical Research - Smithfield /ID# 231912, Smithfield
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Lehigh Center for Clinical Research, Allentown
- Clinical Research Philadelphia, Philadelphia
- Preferred Primary Care Physicians, Inc., Pittsburgh
- och 2 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07645924Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.